Junli Zhao
Junli Zhao, MS, is a Study Director and Toxicokinetics Group Leader at WuXi AppTec in Suzhou, China, with more than a decade of experience in nonclinical toxicology and toxicokinetics. He specialises in GLP toxicology study design, toxicokinetic data analysis and regulatory-compliant reporting. Zhao has extensive expertise in WinNonlin, in vivo disease models and cell culture techniques. He previously worked at the Chinese Academy of Sciences and Xi'an Jiaotong-Liverpool University and has published papers in neurobiology and tumorigenesis.
Contact info
- Article
Understanding the toxicology endpoints that matter in ADC development
Antibody-drug conjugates (ADCs) present unique toxicology challenges. Learn which endpoints matter most, how they inform development decisions and why they are essential for building a robust nonclinical safety strategy.


